Illumina sequencing and array products facilitate clinical cancer research by providing expert-defined gene content, accurate data, and simple analysis and reporting options.
Featured Sequencing Research Panels
AmpliSeq for Illumina Sequencing Panels—Optimized for clinical cancer research applications and available as predesigned or made-to-order panels; use with targets ranging from a few to hundreds of genes in a single run.
TruSight Tumor 170—Comprehensive research panel detects single-nucleotide variants (SNVs), amplifications, and fusions that contribute to solid tumor progression.
TruSight Oncology 500—Assay targeting multiple variant types, including tumor mutational burden (TMB) and microsatellite instability (MSI), even from low-quality samples.
TruSight RNA Fusion—This targeted RNA sequencing research panel is a cost-effective solution to detect gene fusions in multiple cancer types, regardless of origin.
TruSight RNA Pan-Cancer—Targeting 1385 oncology genes for gene expression, variant and fusion detection studies in all RNA sample types including FFPE.
TruSight Tumor 15—Focused research panel to assess relevant solid tumor somatic variants in a simple, sample-to-data workflow.
Infinium OncoArray-500K BeadChip—An expert-designed, high-density array for researching cancer predisposition and risk. Contains ~500,000 genome-wide SNPs, plus putative SNPs associated with breast, colorectal, lung, ovarian, and prostate cancer.